Literature DB >> 22691282

Topical treatment modalities for old world cutaneous leishmaniasis: a review.

R Alavi-Naini1, A Fazaeli, T O'Dempsey.   

Abstract

Diagnosis and therapy of cutaneous leishmaniasis (CL) can be difficult due to the variability of the clinical pictures and resistance to therapy. There is no vaccine currently available for CL. The aim of the present review is to describe different topical treatment modalities for old world CL. The mainstays of treatment for old world CL are pentavalent antimony compounds which are administered parenterally or intralesionally. New topical treatment alternatives have been available within the past few years. Amongst several treatments used topically, physical therapies including cryotherapy, heat therapy and CO2 laser are promising for the treatment of old world CL. Along with that, other randomized placebo controlled trials should be designed to find new effective therapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691282     DOI: 10.14712/23362936.2015.26

Source DB:  PubMed          Journal:  Prague Med Rep        ISSN: 1214-6994


  10 in total

Review 1.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

Review 2.  Ethnomedicines and anti-parasitic activities of Pakistani medicinal plants against Plasmodia and Leishmania parasites.

Authors:  Akash Tariq; Muhammad Adnan; Rahila Amber; Kaiwen Pan; Sakina Mussarat; Zabta Khan Shinwari
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-09-20       Impact factor: 3.944

Review 3.  Plant-derived compounds in treatment of leishmaniasis.

Authors:  A Oryan
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

Review 4.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

Review 5.  Heat therapy for cutaneous leishmaniasis: A literature Review.

Authors:  Amir Hossein Siadat; Fariba Iraji; Azadeh Zolfaghari; Sheila Shariat; Safoura Bokaie Jazi
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

6.  In vitro activity of Alkanna frigida extracts in comparison with glucantime against Leishmania major.

Authors:  Fariba Jafari; Abbasali Nourian; Asghar Fazaeli; Alireza Yazdinezhad; Ali Haniloo
Journal:  Iran J Microbiol       Date:  2013-06

7.  In vitro and in vivo antileishmanial effects of aloe-emodin on Leishmania major.

Authors:  Abdolhossein Dalimi; Mahdi Delavari; Fatemeh Ghaffarifar; Javid Sadraei
Journal:  J Tradit Complement Med       Date:  2015-01-31

8.  Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica.

Authors:  Maryam Hakimi Parizi; Abbas Pardakhty; Iraj Sharifi; Saeedeh Farajzadeh; Mohammad Hossein Daie Parizi; Hamid Sharifi; Ali Reza Keyhani; Mahshid Mostafavi; Mehdi Bamorovat; Daryoush Ghaffari
Journal:  J Parasit Dis       Date:  2019-03-29

9.  A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World.

Authors:  Liliana López; Braulio Valencia; Fiorela Alvarez; Ana Pilar Ramos; Alejandro Llanos-Cuentas; Juan Echevarria; Iván Vélez; Marina Boni; Joelle Rode; Juliana Quintero; Alejandra Jiménez; Yulied Tabares; Claudia Méndez; Byron Arana
Journal:  PLoS Negl Trop Dis       Date:  2022-03-07

10.  A novel function for kojic acid, a secondary metabolite from Aspergillus fungi, as antileishmanial agent.

Authors:  Ana Paula D Rodrigues; Luis Henrique S Farias; Antonio Sérgio C Carvalho; Alberdan S Santos; José Luiz M do Nascimento; Edilene O Silva
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.